Bellerophon Therapeutics
BLPH
#11323
Rank
NZ$0.26 M
Marketcap
NZ$0.02187
Share price
-36.84%
Change (1 day)
-79.31%
Change (1 year)

Earnings for Bellerophon Therapeutics (BLPH)

Earnings in 2023 (TTM): -NZ$17.85 Million

According to Bellerophon Therapeutics 's latest financial reports the company's current earnings are NZ$5.64 Million. In 2022 the company made an earning of -NZ$40.79 Million a decrease over its 2021 earnings that were of -NZ$36.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bellerophon Therapeutics from 2014 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$17.85 Million-56.26%
2022 -NZ$40.79 Million11.03%
2021 -NZ$36.74 Million-24.22%
2020 -NZ$48.48 Million52.25%
2019 -NZ$31.84 Million-37.33%
2018 -NZ$50.81 Million13.34%
2017 -NZ$44.83 Million3.54%
2016 -NZ$43.3 Million-48.98%
2015 -NZ$84.86 Million-22.15%
2014 -NZ$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
NZ$13.15 B-65,510.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.35 Billion 1,594.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Lantheus Holdings
LNTH
NZ$0.69 B-3,568.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
-NZ$0.15 Billion 609.53%๐Ÿ‡บ๐Ÿ‡ธ USA